NEW DELHI: The federal government has negotiated value of Zydus Cadila’s Covid vaccine ZyCoV-D with its producer and the vaccine can be quickly rolled out below the nationwide programme, an official stated.
Nonetheless, the needle free DNA-vaccine ZyCoV-D – which had been given emergency approval for restricted use in all above 12 years of age – can be given to youngsters solely after the Nationwide Technical Advisory Group on Immunisation (NTAGI) submits its detailed pointers for immunisation of youngsters in opposition to Covid-19.
“The negotiation with Zydus Cadila for pricing of ZyCoV-D are over and the procurement value has been fastened. The worth is considerably decrease than what the corporate had quoted initially. The vaccine can be quickly administered as a part of the nationwide programme,” the official advised TOI.
When requested whether or not it might even be administered to youngsters above 12 years of age, the official stated NTAGI is framing pointers to specify precedence teams. The vaccine can be initially out there just for these above 12 years age who’ve particular co-morbidities.